A detailed history of Cary Street Partners Asset Management LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Cary Street Partners Asset Management LLC holds 5,959 shares of ZTS stock, worth $1.04 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,959
Previous 5,927 0.54%
Holding current value
$1.04 Million
Previous $1.17 Million 13.77%
% of portfolio
0.16%
Previous 0.2%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$165.67 - $199.94 $5,301 - $6,398
32 Added 0.54%
5,959 $1.01 Million
Q4 2023

Feb 05, 2024

SELL
$151.44 - $200.09 $11,509 - $15,206
-76 Reduced 1.27%
5,927 $1.17 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $5,849 - $6,746
35 Added 0.59%
6,003 $1.04 Million
Q2 2023

Aug 10, 2023

SELL
$160.94 - $186.23 $20,117 - $23,278
-125 Reduced 2.05%
5,968 $1.03 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $122,747 - $147,391
936 Added 18.15%
6,093 $893,000
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $17,201 - $21,175
-116 Reduced 2.2%
5,157 $765,000
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $5,770 - $7,403
37 Added 0.71%
5,273 $906,000
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $33,557 - $43,295
-185 Reduced 3.41%
5,236 $987,000
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $19,756 - $25,197
-102 Reduced 1.85%
5,421 $1.32 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $78,176 - $86,601
-413 Reduced 6.96%
5,523 $1.07 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $13.3 Million - $16.1 Million
-85,425 Reduced 93.5%
5,936 $1.11 Million
Q1 2021

May 17, 2021

SELL
$144.0 - $169.39 $39,456 - $46,412
-274 Reduced 0.3%
91,361 $1.19 Million
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $14.4 Million - $16 Million
91,635 New
91,635 $1.28 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cary Street Partners Asset Management LLC Portfolio

Follow Cary Street Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Asset Management LLC with notifications on news.